Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy
Epigenetic mechanisms, including DNA methylation and histone post‐translational
modifications (PTMs), have been known to regulate chromatin structure and lineage‐specific …
modifications (PTMs), have been known to regulate chromatin structure and lineage‐specific …
Novel mechanisms targeted by drug trials in pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a rare disease associated with abnormally
elevated pulmonary pressures and right heart failure resulting in high morbidity and …
elevated pulmonary pressures and right heart failure resulting in high morbidity and …
[HTML][HTML] 2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension
SN Avdeev, OL Barbarash, AE Bautin… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic
pulmonary hypertension | Avdeev | Russian Journal of Cardiology Russian Journal of …
pulmonary hypertension | Avdeev | Russian Journal of Cardiology Russian Journal of …
[HTML][HTML] Легочная гипертензия, в том числе хроническая тромбоэмболическая легочная гипертензия. Клинические рекомендации 2020
СН Авдеев, ОЛ Барбараш, АЕ Баутин… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …
Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial
S Rosenkranz, J Feldman, VV McLaughlin… - The Lancet …, 2022 - thelancet.com
Background Data obtained in human lung tissue and preclinical models suggest that
oxidative stress and increased apoptosis signal-regulating kinase 1 (ASK1) activity might …
oxidative stress and increased apoptosis signal-regulating kinase 1 (ASK1) activity might …
Interstitial lung disease in infancy and early childhood: a clinicopathological primer
FP Laenger, N Schwerk, J Dingemann… - European …, 2022 - Eur Respiratory Soc
Children's interstitial lung disease (chILD) encompasses a wide and heterogeneous
spectrum of diseases substantially different from that of adults. Established classification …
spectrum of diseases substantially different from that of adults. Established classification …
Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension
R Auth, JR Klinger - Expert Opinion on Investigational Drugs, 2023 - Taylor & Francis
Introduction Pulmonary arterial hypertension (PAH) is a progressive and life-threatening
disease. Approved treatment options currently primarily target abnormal cell signaling …
disease. Approved treatment options currently primarily target abnormal cell signaling …
Novel molecular mechanisms involved in the medical treatment of pulmonary arterial hypertension
I Martin de Miguel, A Cruz-Utrilla, E Oliver… - International Journal of …, 2023 - mdpi.com
Pulmonary arterial hypertension (PAH) is a severe condition with a high mortality rate
despite advances in diagnostic and therapeutic strategies. In recent years, significant …
despite advances in diagnostic and therapeutic strategies. In recent years, significant …
[HTML][HTML] Chloride channels in the lung: Challenges and perspectives for viral infections, pulmonary arterial hypertension, and cystic fibrosis
Fine control over chloride homeostasis in the lung is required to maintain membrane
excitability, transepithelial transport as well as intra-and extracellular ion and water …
excitability, transepithelial transport as well as intra-and extracellular ion and water …
The effect of hypoxia-inducible factor inhibition on the phenotype of fibroblasts in Human and bovine pulmonary hypertension
CJ Hu, A Laux, A Gandjeva, L Wang, M Li… - American journal of …, 2023 - atsjournals.org
Hypoxia-inducible factor (HIF) has received much attention as a potential pulmonary
hypertension (PH) treatment target because inhibition of HIF reduces the severity of …
hypertension (PH) treatment target because inhibition of HIF reduces the severity of …